VCYT
Veracyte Inc

1,248
Mkt Cap
$3.16B
Volume
990,410.00
52W High
$47.32
52W Low
$22.61
PE Ratio
105.16
VCYT Fundamentals
Price
$40.85
Prev Close
$39.93
Open
$40.86
50D MA
$36.07
Beta
1.66
Avg. Volume
754,303.17
EPS (Annual)
$0.3088
P/B
2.51
Rev/Employee
$540,975.73
Loading...
Loading...
News
all
press releases
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from Analysts
Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) has earned an average rating of "Moderate Buy" from the ten research firms that are currently covering the firm, Marketbeat reports. One analyst has...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
TDOC Partners With TytoCare to Expand At-Home Exam Capabilities
Teladoc Health deepens its virtual care reach by adding TytoCare's at-home exam tech to Primary360 and 24/7 Care starting in 2026.
Zacks·1d ago
News Placeholder
Veracyte (NASDAQ:VCYT) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of Veracyte from a "buy" rating to a "strong-buy" rating in a research report on Sunday...
MarketBeat·5d ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Veracyte, Inc. $VCYT
Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 19.2% in the second quarter, according to the company in its most recent...
MarketBeat·7d ago
News Placeholder
Ensign Group Shares Decline 2.2% Despite Q3 Earnings Beat
ENSG shares slip 2.2% despite Q3 earnings and revenues topping estimates, as higher service and rent costs weigh on results.
Zacks·7d ago
News Placeholder
Morgan Stanley Raises Veracyte (NASDAQ:VCYT) Price Target to $40.00
Morgan Stanley boosted their price target on shares of Veracyte from $28.00 to $40.00 and gave the company an "underweight" rating in a report on Tuesday...
MarketBeat·8d ago
News Placeholder
Encompass Health Shares Down 8% Despite Q3 Earnings & Revenue Beat
EHC shares fall 8% after Q3 results, as higher costs offset revenue gains, bed expansions and an upbeat 2025 outlook.
Zacks·9d ago
News Placeholder
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up
Veracyte surges 27.5% after Q3 earnings and revenues beat estimates, driven by strong Decipher and Afirma test growth.
Zacks·9d ago
News Placeholder
Tenet Healthcare Shares Down 5% Despite Q3 Earnings Beat
THC's Q3 profit beats estimates on higher revenues and strong segment growth, but rising costs drag shares lower.
Zacks·10d ago
News Placeholder
Vestmark Advisory Solutions Inc. Acquires 81,007 Shares of Veracyte, Inc. $VCYT
Vestmark Advisory Solutions Inc. raised its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 84.2% in the 2nd quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·11d ago

Latest VCYT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.